SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-006284
Filing Date
2020-09-04
Accepted
2020-09-04 14:50:07
Documents
13
Period of Report
2020-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_090420.htm 6-K 9691
2 EXHIBIT 99.1 exh_991.htm EX-99.1 353009
3 EXHIBIT 99.2 exh_992.htm EX-99.2 39234
4 GRAPHIC medicennalogo.jpg GRAPHIC 13506
5 GRAPHIC performancegraph.jpg GRAPHIC 52709
6 GRAPHIC davidson_footer.jpg GRAPHIC 7111
7 GRAPHIC davidson_logo.jpg GRAPHIC 8043
8 GRAPHIC davidson_sig.jpg GRAPHIC 4282
9 GRAPHIC pwc_footer.jpg GRAPHIC 7433
10 GRAPHIC pwc_logo.jpg GRAPHIC 3562
11 GRAPHIC pwc_sig.jpg GRAPHIC 6941
12 GRAPHIC tmxlogo.jpg GRAPHIC 9027
13 GRAPHIC exh_992yellowblock.jpg GRAPHIC 673
  Complete submission text file 0001171843-20-006284.txt   544152
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 201161734
SIC: 2834 Pharmaceutical Preparations